Search

Friday 21 June 2024

CRSP U.S. FDA approved first therapy utilising CRISPR

The beginning of a new era in medicine: The U.S. FDA has today approved cell-based gene therapy Casgevy, marking the first FDA-approved therapy utilising the genome editing technology CRISPR (NASDAQ:CRSP) | https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapies-treat-patients-sickle-cell-disease
#FDA #CRISPR #shorts

Free stock updates

Subscribe to receive the latest stock news, CEO interviews, expert insights, events and offers directly into your inbox